http://www.iconplc.com/news-events/news//xmlNew module improves the quality, consistency and compliance of investigator training. http://www.iconplc.com/news-events/news/icon-releases-new-web-bas/index.xmlWed, 09 May 2012 14:20:09 GMTDublin, Ireland, April 24, 2012 – ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2012. http://www.iconplc.com/news-events/news/icon-reports-a-10-increas/index.xmlTue, 24 Apr 2012 11:10:42 GMTICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, and global consulting firm Booz & Company co-authored the report, titled “Nimble Partnerships in the Pharma Industry: Well-Designed CRO Relationships Enhance Focus and Flexibility.”http://www.iconplc.com/news-events/news/nimble-approach-to-partne/index.xmlTue, 10 Apr 2012 13:00:00 GMTICON today announced that it has been selected by Roche as its technology partner for storing and managing medical images collected during the company’s clinical research programs. http://www.iconplc.com/news-events/news/icon-selected-by-roche-fo/index.xmlMon, 05 Mar 2012 10:12:05 GMTICON today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition strengthens ICON’s expertise in value based pricing and market access, and together with the health economics and patient reported outcomes services acquired through Oxford Outcomes, enables ICON to offer the industry’s most integrated regulatory, clinical and market access solution. http://www.iconplc.com/news-events/news/icon-acquires-pricespecti/index.xmlTue, 28 Feb 2012 11:32:12 GMTICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. http://www.iconplc.com/news-events/news/icon-reports-fourth-quart-1/index.xmlThu, 16 Feb 2012 11:05:30 GMTThe acquisition enhances ICON’s existing service capabilities and delivery in the region through the addition of over 100 highly qualified and experienced BeijingWits professionals located in Beijing, Shanghai, Chengdu, Guangzhou, Wuhan and Hong Kong. http://www.iconplc.com/news-events/news/icon-completes-acquisitio/index.xmlWed, 15 Feb 2012 22:34:39 GMTICON’s Scientific Council is a team of ICON experts with broad industry experience and knowledge of the scientific, technical and therapeutic aspects of product development, from concept through to approval.http://www.iconplc.com/news-events/news/icon-strengthens-global-s/index.xmlTue, 24 Jan 2012 12:09:35 GMTICON has signed a strategic partnership with Shire plcs's Specialty Pharmaceuticals which will see it serve as the sole global provider of central laboratory services and one of two strategic partners for clinical development services. http://www.iconplc.com/news-events/news/icon-selected-by-shire-as/index.xmlMon, 09 Jan 2012 08:59:51 GMTICON today announced the retirement of Non-Executive Director, Dr. Anthony Murphy to become effective on 31st December 2011.http://www.iconplc.com/news-events/news/icon-announces-dr.-anthon/index.xmlTue, 27 Dec 2011 14:46:40 GMTICON today announced that it has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting Ltd., a leading CRO in China. The transaction is expected to close in the first quarter of 2012.http://www.iconplc.com/news-events/news/icon-acquires-beijingwits/index.xmlMon, 12 Dec 2011 09:58:05 GMTICON today announced that its Development Solutions division has appointed Dr. Daniel Tang as General Manager, Asia Pacific. Dr. Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with Key Opinion Leaders for early phase clinical testing. http://www.iconplc.com/news-events/news/icon-development-solution-3/index.xmlMon, 28 Nov 2011 09:59:50 GMTICON will now begin to repurchase shares pursuant to the approval by its Board of Directors of a share buyback of up to $50m, as indicated in the Company’s Q3 results issued on 27 October 2011. http://www.iconplc.com/news-events/news/icon-plc-commencement-of-/index.xmlTue, 22 Nov 2011 22:20:00 GMTICON today announced that it has been selected by Tasly Pharmaceuticals 600535.SH) for the company’s global Phase III T89 trial. T89, also known as Dantonic® pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States. http://www.iconplc.com/news-events/news/tasly-pharmaceuticals-sel/index.xmlMon, 21 Nov 2011 10:25:24 GMTICON today announced that its Medical Imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.http://www.iconplc.com/news-events/news/icon-medical-imaging-rate/index.xmlThu, 17 Nov 2011 10:26:36 GMTICON's resourcing division, DOCS, has opened four new offices in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany.http://www.iconplc.com/news-events/news/docs-continues-expansion-/index.xmlWed, 16 Nov 2011 12:09:49 GMTICON and Empire Genomics, a leading provider of genomic technologies that enable personalised medicine to be realised, today announced the formation of a strategic alliance.http://www.iconplc.com/news-events/news/icon-plc-and-empire-genom/index.xmlWed, 09 Nov 2011 16:53:09 GMTICON today announced that it has won the Clinical Research Team of the Year award at the annual 2011 Scrip Awards.http://www.iconplc.com/news-events/news/icon-wins-clinical-resear/index.xmlMon, 07 Nov 2011 17:44:42 GMTICON today announced that Dr.Steve Cutler will join the company as Group President, Clinical Research Services. http://www.iconplc.com/news-events/news/icon-names-new-global-hea/index.xmlTue, 01 Nov 2011 11:02:21 GMTICON a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the third quarter ended September 30, 2011. http://www.iconplc.com/news-events/news/icon-reports-q3-revenue-g/index.xmlThu, 27 Oct 2011 11:05:00 GMT